#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Short stature Chondrosarcoma metastatic Small cell lung cancer Medullary thyroid cancer Familial haemophagocytic lymphohistiocytosis Graft versus host disease Atopic keratoconjunctivitis Lymphangioma Kawasaki's disease Erythema Bladder cancer Myeloid leukaemia PIK3CA-activated mutation Hairy cell leukaemia recurrent Neuroendocrine tumour of the lung More trials…

    Learn about Rare Diseases

    Pemphigus – Basic Information Pleomorphic leiomyosarcoma Congenital generalised lipodystrophy – Trials in Disease Lymphangiosarcoma – Life with Disease Retinoblastoma – Trials in Disease Rhabdomyosarcoma – Basic Information Progressive multifocal leukoencephalopathy Primary hyperoxaluria – Treatment Antithrombin III deficiency Ewing’s sarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nedosiran Sodium 2-Hydroxylinoleate Vh4524184 Surzebiclimab Topiramate Magnesium Oxybate Milademetan HUMAN PLASMA Imsidolimab Larotrectinib Sulfate GSKVX000000048111 Dimethyl Fumarate Daxdilimab Cenobamate Resamirigene Bilparvovec DICLOFENAC POTASSIUM Trientine Dihydrochloride Latozinemab Methoxsalen Rigosertib Sodium More therapies…

    Learn about Your Condition

    Hepatic adenoma Liposarcoma metastatic Primary adrenal insufficiency Juvenile absence epilepsy Pigmentary glaucoma Ischaemic stroke Apathy Ewing's sarcoma Venous thrombosis Eye inflammation Cervix carcinoma stage III Mantle cell lymphoma stage III Cryoglobulinaemia Anogenital dysplasia K-ras gene mutation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Entecavir
    • Ianalumab
    • Tenofovir Disoproxil
    Austria Belgium France Germany Greece Hungary +4

  • Study on the Effectiveness and Safety of Mitomycin C with Electric Current for Treating Non-Muscle Invasive Bladder Cancer in Patients, Compared to Standard Immunotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma
    Investigated Drugs:
    • Mitomycin
    Spain

  • Study on the Effects of Dexamethasone in Adults with Acute Respiratory Failure Due to Infections, Including COVID-19

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory failure
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    Spain

  • Study on Setmelanotide for Improving Hypothalamic Function in Patients with ROHHAD Syndrome

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • ROHHAD syndrome
    Investigated Drugs:
    • Setmelanotide
    The Netherlands

  • Study on the Effects of Ensifentrine for Patients with Non-Cystic Fibrosis Bronchiectasis

    Recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • ENSIFENTRINE
    Italy Spain

  • Study of alpha-1 antitrypsin given intravenously to hospitalized patients during COPD exacerbation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Human Alpha1-Proteinase Inhibitor
    • Sodium Chloride
    Italy
Previous Page
1 … 284 285 286 287 288 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!